Abstract:Introduction: The availability of highly effective triple cystic fibrosis transmembrane conductance regulator ( CFTR ) modulator combination therapy with elexacaftor–tezacaftor–ivacaftor (ETI) has improved pulmonary outcomes and quality of life of people with cystic fibrosis (pwCF). The aim of this study was to assess computed tomography (CT) changes under ETI visually with the Brody score and quantitatively with dedicated software, and to correlate CT measures with parameters of clinical response. Methods: Twenty two adult pwCF with two consecutive CT scans before and after ETI treatment initiation were retrospectively included. CT was assessed visually employing the Brody score and quantitatively by YACTA, a well-evaluated scientific software computing airway dimensions and lung parenchyma with wall percentage (WP), wall thickness (WT), lumen area (LA), bronchiectasis index (BI), lung volume and mean lung density (MLD) as parameters. Changes in CT metrics were evaluated and the visual and quantitative parameters were correlated with each other and with clinical changes in sweat chloride concentration, spirometry [percent predicted of forced expiratory volume in one second (ppFEV 1 )] and body mass index (BMI). Results: The mean (SD) Brody score improved with ETI [55 (12) vs. 38 (15); p < 0.001], incl. sub-scores for mucus plugging, peribronchial thickening, and parenchymal changes (all p < 0.001), but not for bronchiectasis ( p = 0.281). Quantitatve WP ( p < 0.001) and WT ( p = 0.004) were reduced, conversely LA increased ( p = 0.003), and BI improved ( p = 0.012). Lung volume increased ( p < 0.001), and MLD decreased ( p < 0.001) through a reduction of ground glass opacity areas ( p < 0.001). Changes of the Brody score correlated with those of quantitative parameters, exemplarily WT with the sub-score for mucus plugging (r = 0.730, p < 0.001) and peribronchial thickening (r = 0.552, p = 0.008). Changes of CT parameters correlated with those of clinical response parameters, in particular ppFEV 1 with the Brody score (r = −0.606, p = 0.003) and with WT (r = −0.538, p = 0.010). Discussion: Morphological treatment response to ETI can be assessed using the Brody score as well as quantitative CT parameters. Changes in CT correlated with clinical improvements. The quantitative analysis with YACTA proved to be an objective, reproducible and simple method for monitoring lung disease, particularly with regard to future interventional clinical trials.

Quantitative CT measures are sensitive to clinical bronchiectasis severity: preliminary data from the BRILLIANT study

Structural Lung Disease and Clinical Phenotype in Bronchiectasis Patients: The EMBARC CT Study

Quantitative CT Metrics for the Prediction of Therapeutic Effect in Asthma.

Relationship Between Quantitative CT Metrics and Health Status and BODE in Chronic Obstructive Pulmonary Disease

Computerized Identification of Bronchiectasis Using a 3D Quantitative CT Protocol

Association of bronchial disease on CT imaging and clinical definitions of chronic bronchitis in a single-center COPD phenotyping study

The Clinical Significance of Quantitative Analysis of Bronchiectasis Based on Three-Dimensional Bronchial Partition

Small-airway Dysfunction among Non-Cystic Bronchiectasis Patients with Different Bronchiectasis Severity Index

Use of Quantitative CT Imaging to Identify Bronchial Thermoplasty Responders

Quantitative Analysis of CT Lung Density in Patients with Chronic Asthma by High-Resolution Computed Tomography

Qualitative and quantitative evaluation of computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: a retrospective observational study

Quantitative study on the degree of small airway disease and emphysema injury in pulmonary lobes of patients with smoking combined with chronic obstructive pulmonary disease based on biphasic CT

CT-detected pulmonary vascular changes are associated with measures of small airways disease in smokers

Relationship of computed tomography-based measurements with symptom perception and quality of life in patients with severe asthma

Bronchiectasis in severe asthma: clinical and inflammatory response to biologic therapy.

Increased chemokines levels in patients with chronic obstructive pulmonary disease: correlation with quantitative computed tomography metrics

The Research Value of Biphasic Registration Quantitative Computed Tomography Emphysema Index in the Evaluation of Mild to Moderate COPD

CT densitometry in emphysema: a systematic review of its clinical utility

Quantitative CT Parameters Correlate with Lung Function in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

Diaphragmatic Ultrasound in Non-Cystic Fibrosis Bronchiectasis: Relationship to Clinical Parameters

Prevalence, Severity, and Associated Features—A Cohort Study